Abbasciano V, Levato F, Zavagli G
Istituto di Patologia Medica, Università di Ferrara, Italy.
Med Oncol Tumor Pharmacother. 1989;6(2):129-32. doi: 10.1007/BF02985235.
In 98 patients affected by colorectal cancer (43 patients with colon cancer, 55 patients with rectosigmoid cancer) the specificity of some tumor markers (CEA, GICA, TPA, alpha-FP, FpA, gamma-GT) has been tested in evidencing the coexistence of liver metastases and the site of the primary tumor, i.e. the rectosigmoid region (rectum + 15 cm of the adjacent sigmoid colon) vs the rest of the colon. Liver metastases, present in 19 patients with colon cancer and in 24 with recto-sigmoid cancer, were previously ascertained by various instrumental investigations. Unlike previous studies which indicated CEA or alpha-FP as the most reliable markers to suggest the coexistence of liver metastases in such patients, the reported results allow the following sequence, in decreasing order of sensitivity, to be proposed: gamma-GT; FpA; CEA and GICA to a similar degree; TPA, which increases only when liver metastases from colon cancer are present; lastly, alpha-FP, which rises only in very few cases of massive hepatic involvement.
在98例结直肠癌患者(43例结肠癌患者,55例直肠乙状结肠癌患者)中,对一些肿瘤标志物(癌胚抗原、胃肠道癌相关抗原、组织多肽抗原、甲胎蛋白、纤维蛋白原A、γ-谷氨酰转移酶)在检测肝转移瘤共存情况以及原发肿瘤部位(即直肠乙状结肠区域(直肠+相邻乙状结肠15厘米)与结肠其他部位)方面的特异性进行了测试。19例结肠癌患者和24例直肠乙状结肠癌患者存在肝转移瘤,此前已通过各种仪器检查确定。与先前表明癌胚抗原或甲胎蛋白是提示此类患者肝转移瘤共存的最可靠标志物的研究不同,报告结果按敏感性从高到低的顺序得出以下序列:γ-谷氨酰转移酶;纤维蛋白原A;癌胚抗原和胃肠道癌相关抗原程度相似;组织多肽抗原,仅在存在结肠癌肝转移时升高;最后是甲胎蛋白,仅在极少数广泛肝脏受累的情况下升高。